COEP - Coeptis Therapeutics Holdings, Inc.

13.19
0.730   5.534%

Share volume: 73,579
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances: 0.19%

PREVIOUS CLOSE
CHG
CHG%
$12.46
0.73
0.06%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
33%
Profitability 35%
Dept financing 33%
Liquidity 36%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
13.71%
1 Month
7.59%
3 Months
-14.35%
6 Months
1.85%
1 Year
24.50%
2 Year
2,542.23%
Key data
Stock price
$13.19
P/E Ratio 
0.00
DAY RANGE
$12.21 - $13.19
EPS 
-$8.46
52 WEEK RANGE
$6.26 - $21.41
52 WEEK CHANGE
$21.01
MARKET CAP 
84.163 M
YIELD 
N/A
SHARES OUTSTANDING 
5.340 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
12-31-2024
NEXT EARNINGS DATE
04-29-2025
BETA 
1.20
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$33,281
AVERAGE 30 VOLUME 
$44,957
Company detail
CEO: David Mehalick
Region: US
Website: coeptispharma.com
Employees: 2
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Sector: Manufacturing

Bull Horn Holdings Corp. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination. The company was founded in 2018 and is based in Miami Beach, Florida.

Recent news